Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007282
Disease: Carotid Stenosis
Carotid Stenosis
0.020 GeneticVariation disease BEFREE In white subjects, carotid artery stenosis was associated with significantly elevated total cholesterol and low density lipoprotein (p less than 0.01) but not with Sac I polymorphism. 1355620 1992
CUI: C0007282
Disease: Carotid Stenosis
Carotid Stenosis
0.020 GeneticVariation disease BEFREE In white subjects, carotid artery stenosis was associated with significantly elevated total cholesterol and LDL levels (P < .01) but not with Sac I polymorphism. 8249016 1993
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.020 GeneticVariation disease BEFREE In white subjects, carotid artery stenosis was associated with significantly elevated total cholesterol and low density lipoprotein (p less than 0.01) but not with Sac I polymorphism. 1355620 1992
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.020 GeneticVariation disease BEFREE In black subjects, Sac I polymorphism appears to identify individuals with significant carotid stenosis, a necessary precursor to atherothrombotic brain infarction, but not those with elevated total cholesterol or LDL and/or reduced HDL levels. 8249016 1993
Hyperthyroxinemia, Familial Dysalbuminemic
0.020 GeneticVariation disease BEFREE In every individual with FDH, the mutation was associated with the Sac I+ polymorphism in the albumin gene, strongly suggesting a founder effect. 8048949 1994
Hyperthyroxinemia, Familial Dysalbuminemic
0.020 GeneticVariation disease BEFREE An intragenic Sac-1 polymorphic site was found in association with the specific FDH mutation, suggesting a founder effect. 12099390 2002
CUI: C0751955
Disease: Brain Infarction
Brain Infarction
0.020 GeneticVariation disease BEFREE These results suggest that Sac I polymorphism may identify black subjects at increased risk for atherothrombotic brain infarctions. 1355620 1992
CUI: C0751955
Disease: Brain Infarction
Brain Infarction
0.020 GeneticVariation disease BEFREE These results suggest that Sac I polymorphism may identify black subjects at increased risk for atherothrombotic brain infarctions. 8249016 1993
CUI: C0003873
Disease: Rheumatoid Arthritis
Rheumatoid Arthritis
0.010 GeneticVariation disease BEFREE To examine the hypothesis that a hereditary factor linked to the immunoglobulin kappa constant segment (C kappa) contributes to risk of rheumatoid arthritis (RA), white persons with RA were examined for Sac I restriction site polymorphisms. 2497749 1989
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.010 AlteredExpression disease BEFREE These results suggest that SAC1 expression and PI(4)P at the Golgi are important in tumor progression and metastasis and are potential prognostic markers of breast cancers. 27178239 2016
CUI: C0008533
Disease: Hemophilia B
Hemophilia B
0.010 Biomarker disease BEFREE In 22 Japanese families with hemophilia B, 18 families (81.8%) were heterozygous for at least one of these polymorphisms, whereas 11 (50%) were informative for the extragenic DXS99/Sac I RFLP which was previously reported as a useful gene marker for Japanese hemophilia B. 8560402 1995
CUI: C0011847
Disease: Diabetes
Diabetes
0.010 GeneticVariation disease BEFREE A restriction-fragment-length polymorphism (RFLP) detected with the human insulin-receptor cDNA and the enzyme Sac I has been reported to be associated with non-insulin-dependent diabetes mellitus (NIDDM) in White and Black populations and segregated with diabetes in two small pedigrees with maturity-onset diabetes of the young. 2566545 1989
Diabetes Mellitus, Non-Insulin-Dependent
0.010 Biomarker disease BEFREE A restriction-fragment-length polymorphism (RFLP) detected with the human insulin-receptor cDNA and the enzyme Sac I has been reported to be associated with non-insulin-dependent diabetes mellitus (NIDDM) in White and Black populations and segregated with diabetes in two small pedigrees with maturity-onset diabetes of the young. 2566545 1989
CUI: C0023418
Disease: leukemia
leukemia
0.010 Biomarker disease BEFREE Here we report a case of a 3-year old boy bearing a novel MLL-rearrangement with the suppressor of actin mutations 1-like (SACM1L) gene in the absence of leukemia. 20553989 2010
CUI: C0023449
Disease: Acute lymphocytic leukemia
Acute lymphocytic leukemia
0.010 Biomarker disease BEFREE Bone marrow cells harboring the MLL-SACM1L rearrangement appeared during chemotherapy for acute lymphoblastic leukemia with hyperdiploidy and were continuously detected over 7 years without clonal expansion. 20553989 2010
CUI: C0023492
Disease: Leukemia, T-Cell
Leukemia, T-Cell
0.010 Biomarker disease BEFREE The digestion patterns with 3 restriction endonucleases, Sac I, Eco RI and PstI, of the proviruses integrated in T-lymphoid cell lines derived from the CSF of 4 HAM patients were similar to those of HTLV-1 from adult T-cell leukemia (ATL) patients. 2841247 1988
CUI: C0023493
Disease: Adult T-Cell Lymphoma/Leukemia
Adult T-Cell Lymphoma/Leukemia
0.010 Biomarker disease BEFREE The digestion patterns with 3 restriction endonucleases, Sac I, Eco RI and PstI, of the proviruses integrated in T-lymphoid cell lines derived from the CSF of 4 HAM patients were similar to those of HTLV-1 from adult T-cell leukemia (ATL) patients. 2841247 1988
CUI: C0151718
Disease: Hypocholesterolemia
Hypocholesterolemia
0.010 Biomarker disease BEFREE OSBP and Sac1 co-localized at apparent ER-Golgi contact sites in response to 25-hydroxycholesterol (25OH), cholesterol depletion and p38 MAPK inhibitors. 28471037 2017
CUI: C0221106
Disease: Alkalemia
Alkalemia
0.010 Biomarker disease BEFREE Furthermore, as increasing pH from 4 to 7, the Hg adsorption capacity of SAC1 decreased by 22% (i.e., 0.27 μg mg<sup>-1</sup>). 30384226 2019
CUI: C0234533
Disease: Generalized seizures
Generalized seizures
0.010 GeneticVariation disease BEFREE The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures. 23804563 2013
Maturity onset diabetes mellitus in young
0.010 Biomarker disease BEFREE A restriction-fragment-length polymorphism (RFLP) detected with the human insulin-receptor cDNA and the enzyme Sac I has been reported to be associated with non-insulin-dependent diabetes mellitus (NIDDM) in White and Black populations and segregated with diabetes in two small pedigrees with maturity-onset diabetes of the young. 2566545 1989
CUI: C1096063
Disease: Drug Resistant Epilepsy
Drug Resistant Epilepsy
0.010 GeneticVariation disease BEFREE Autosomal recessive inherited variants in SYNJ1 have previously been associated with two different neurological diseases: a recurrent homozygous missense variant (p.Arg258Gln) that abolishes Sac1 phosphatase activity was identified in three independent families with early onset parkinsonism, whereas a homozygous nonsense variant (p.Arg136*) causing a severe decrease of mRNA transcript was found in a single patient with intractable epilepsy and tau pathology. 27435091 2016
CUI: C1264041
Disease: von Willebrand Disease, Type 3
von Willebrand Disease, Type 3
0.010 GeneticVariation disease BEFREE Linkage was also established in four families between the Sac I and two Taq I RFLPs and the inheritance of type III vWD. 1351407 1992
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.010 Biomarker disease BEFREE Here we report a case of a 3-year old boy bearing a novel MLL-rearrangement with the suppressor of actin mutations 1-like (SACM1L) gene in the absence of leukemia. 20553989 2010
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.010 GeneticVariation disease BEFREE A subset of 77 ASPs with positive sign of Logarithm of Odds (LOD) score showed significant linkage to CAD trait by multi-point analysis (LOD score 7.42, P < 0.001) and to Sac1 (LOD score 4.49) and -75G>A (LOD score 2.77) SNPs by single-point analysis (P < 0.001). 18801202 2008